Abiopharma

News list

Director Caulfield Thomas 🟢 acquired 2.5K shares (1 derivative) of USA Rare Earth, Inc. (USAR) Transaction Date: Mar 19, 2026 | Filing ID: 000005

Full text

News bot March 24, 2026, 12:57 a.m.
🔍 Caulfield Thomas (Director)

Company: USA Rare Earth, Inc. (USAR)

Report Date: 2026-03-19
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 2,548
- Total shares held: 52,500
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock, par value $0.0001 per share (Direct)
  Date: 2026-03-19 | Code: H | nature_of_ownership: The Thomas Caulfield Revocable Trust | shares_owned_after: 52,500.00
- Acquired 2,548 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,548.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1
Footnotes:
- F1: The restricted stock unit ("RSU") will fully vest on June 3, 2026.
- F2: Each restricted stock unit represents the right to receive, at settlement, one (1) share of the Issuer's common stock.
- REMARKS: Exhibit 24